Former California pot exec accused of fraud – InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.ℱ

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Life Insurance News
    • Annuity News
    • Health/Employee Benefits
    • Property and Casualty
    • Advisor News
    • Washington Wire
    • Regulation News
    • Sponsored Articles
    • Monthly Focus
  • INN Exclusives
  • NewsWires
  • Magazine
  • Webinars
  • Free Newsletters
Sign in or register to be an INNsider.
  • Exclusives
  • NewsWires
  • Magazine
  • Webinars
  • Free Newsletters
  • Insider Pro
  • About
  • Advertise
  • Editorial Staff
  • Contact
  • Newsletters

Get Social

  • Facebook
  • Twitter
  • LinkedIn
Advisor News
Newswires RSS Get our newsletter
Order Prints
September 12, 2022 Newswires No comments
Share
Share
Tweet
Email

Former California pot exec accused of fraud

Press-Telegram (Long Beach, CA)
The U.S. Securities and Exchange Commission has charged a former Garden Grove cannabis company executive with fraudulently selling more than $475,000 in unregistered securities to six investors.

A lawsuit filed late last month in U.S. District Court alleges securities registration violations against Nicolas Arkells, 33, of Lawndale, who was employed as the chief strategy and business development officer for C3 International Inc. from June through December 2018.

Arkells is also listed as a principal with a purported real estate investment firm in Redondo Beach but does not hold any securities licenses and has never been a registered broker, according to the SEC.

Related stories

  • Fed slows rate hikes even as Powell says there's more work to do
  • Mortgage rates in U.S. fall again, hit 6.09%

The SEC is requesting that Arkells be ordered to pay undisclosed civil penalties and seeks an injunction preventing him from purchasing or selling securities.

In a related, pending case, the SEC in 2021

charged C3 Chief Executive Officer Steele Clarke Smith III and his wife, Theresa Smith, 60, both of Garden Grove, with allegedly defrauding at least 40 investors out of about $2 million.

C3 manufactured and sold Idrasil, a cannabis pill that purportedly has the medicinal and therapeutic benefits of medical cannabis, according to the company’s website.

Idrasil is considered a nutraceutical, a food, or parts of food, that provides medical or health benefits, so it doesn’t need FDA approval, Steele Smith told the Orange County Register in 2011.

At the time, he said his motivation to help those facing serious illness and pain stemmed partly from his own health experience. Diagnosed in 1998 with Zollinger-Ellison, a rare disorder characterized by tumors and ulcers in the stomach and digestive organs, Steele Smith became addicted to prescription painkillers.

Neither Steele Smith nor Arkells could be reached for comment.

On July 31, 2018, Arkells, despite knowing C3 had no business operations, manufacturing facility, products or revenue, provided false and misleading business summaries and financial projections prepared by Steele Smith to prospective investors showing a minimum of $75 million in gross revenue, the lawsuit states.

The following day, Arkells allegedly forwarded a potential financial backer an email from Steel Smith showing that C3 would generate revenue of $54 million in 2018, even though the company was selling no product and the year was more than half over.

“After reviewing these documents and speaking with Steele Smith and defendant, a prospective investor emailed defendant to indicate he would like to invest $100,000 in C3,” says the suit.

The SEC alleges Steele Smith misappropriated the investor’s funds, using about $40,000 as a down payment on a Jeep Trackhawk.

Steele Smith knew that sales of Idrasil never earned more than $57,000 in any year, and that pills were no longer being manufactured, and there were no plans to make more, according to the SEC.

Arkells also falsely told at least two potential investors C3 had received a $30 million infusion of capital from a private equity group, telling one of them the company’s stock would go up eight to 10 times in value during the coming year, according to the complaint.

“Because of this and similar misrepresentations made by defendant, the investor sent $250,000 to C3 and lost his entire investment,” the lawsuit states.

The complaint also alleges that Arkells, who collected $66,205 in commissions from C3, drafted scripts with false claims for the company’s employees to use with prospective investors.

[email protected]

Older

Equestrian Insurance Market to Witness Huge Growth by 2027: Madden Equine Insurance, AXA, Markel

Newer

Fed will need ‘great skill’ and ‘good luck’ to bring down inflation without crashing the economy, Yellen says

Advisor News

  • Fed slows rate hikes even as Powell says there's more work to do
  • Mortgage rates in U.S. fall again, hit 6.09%
  • 1 in 3 Americans struggling financially but goal-setting is a game-changer
  • Advisors bet on US stocks to outperform in 2023 amid tech rebound
  • Investors want more ESG information from companies
More Advisor News

Annuity News

  • Study: Does pessimism really suppress annuity sales?
  • Sweet streams of income: ChatGPT, the bard of annuities
  • F&G Annuities & Life announces equity investment in life IMO SYNCIS
  • Investors scrambling to lock in rates propel annuity sales to record highs
  • North American and Annexus launch new fixed index annuity
Sponsor
More Annuity News

Health/Employee Benefits News

  • State: all insurers failed to comply with Oregon Reproductive Health Equity Act
  • Will plan fix California health care?
  • Insurance giant Elevance to move into 15th state
  • Medicare card scam targets seniors for personal info
  • Yes, states are re-checking Medicaid and CHIP eligibility starting in April
More Health/Employee Benefits News

Life Insurance News

  • Chris Wilson tells court former friend Murdaugh confessed he was ‘stealing money’
  • State's motive testimony could prolong Alex Murdaugh murder trial
  • Equitable expands portfolio in VUL market
  • New date set for billionaire suspect accused of bribing state cabinet member
  • House approves bill protecting life insurance payouts from bankruptcy
More Life Insurance News

- Presented By -

Top Read Stories

  • Chicago news roundup: PPP fraud uncovered in Chicago, informant reveals $100K bounty on FBG Duck and more
  • Gov. Carney: Enrollment on Delaware's Health Insurance Marketplace for 2023 Reaches All-Time High
  • 25 people charged in fake nursing diploma operation
  • Missouri Department of Insurance: Over $24 Million Returned To Missouri Insurance Consumers In 2022
  • Connecticut addressing broker shortage amid The Great Unwinding
More Top Read Stories >

FEATURED OFFERS

Meet Encova Life
We know agents matter. You can count on our life team to be high tech, high touch and responsive.

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Life Insurance News
  • Annuity News
  • Health/Employee Benefits
  • Property and Casualty
  • Advisor News
  • Washington Wire
  • Regulation News
  • Sponsored Articles
  • Monthly Focus

Top Sections

  • Life Insurance News
  • Annuity News
  • Health/Employee Benefits News
  • Property and Casualty News
  • AdvisorNews
  • Washington Wire
  • Insurance Webinars

Our Company

  • About
  • Editorial Staff
  • Magazine
  • Write for INN
  • Advertise
  • Contact

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2023 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • AdvisorNews

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.